View in EDS

PCN70 Cost-Effectiveness of Cetuximab and Bevacizumab in the First-Line Treatment of Metastatic Colorectal Cancer (mCRC) for Patients with Kras Wild-Type Tumours in the United Kingdom

Saved in:
Bibliographic Details
Title: PCN70 Cost-Effectiveness of Cetuximab and Bevacizumab in the First-Line Treatment of Metastatic Colorectal Cancer (mCRC) for Patients with Kras Wild-Type Tumours in the United Kingdom
Authors: Samyshkin, Y.1, Hertel, N.1, Griebsch, I.2
Source: Value in Health. pA446-A447. 0p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first